Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies

Detalles Bibliográficos
Autores principales: Dragoni, Filippo, Schiaroli, Elisabetta, Micheli, Valeria, Fiaschi, Lia, Lai, Alessia, Zehender, Gianguglielmo, Rossetti, Barbara, Gismondo, Maria Rita, Francisci, Daniela, Zazzi, Maurizio, Vicenti, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923034/
https://www.ncbi.nlm.nih.gov/pubmed/35304279
http://dx.doi.org/10.1016/j.cmi.2022.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923034/
https://www.ncbi.nlm.nih.gov/pubmed/35304279
http://dx.doi.org/10.1016/j.cmi.2022.03.005

Ejemplares similares